Study of Normal Heart Structure and Function in Healthy Chinese Adults Using Magnetic Resonance Imaging
Led by Chinese Academy of Medical Sciences, Fuwai Hospital · Updated on 2023-01-04
938
Participants Needed
1
Research Sites
25 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are conducting a study to establish age- and sex-specific normal values for heart structure and function in healthy Chinese adults. This includes using advanced cardiovascular magnetic resonance CMR techniques like steady-state free precession and novel methods to assess myocardial strain and tissue characteristics. The study aims to fill the gap in existing reference standards for cardiovascular measurements specific to the Chinese population, supporting better diagnosis and prognosis of heart diseases.
The study involves no treatment or intervention as it is observational. Participants undergo cardiovascular magnetic resonance imaging to measure traditional and novel heart parameters. Data collected will contribute to a comprehensive database of normal heart values for Chinese adults, enhancing the understanding of heart health and assisting future cardiovascular research.
Participants will be healthy volunteers without cardiovascular conditions or risk factors. They will undergo imaging sessions and clinical assessments to provide detailed heart structure and function data. The study will monitor the normal values of left and right heart structures and functions, as well as novel CMR parameters, over five years. This information will help improve early identification and prognosis of cardiovascular diseases.
CONDITIONS
Brief Title
Cardiac Normal Values Assessed by Magnetic Resonance Imaging
Research Team
M
Minjie Lu
B
Baiyan Zhuang
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Chinese Academy of Medical Sciences, Fuwai Hospital
Lead Sponsor
Who Can Participate
Age: 0 - 80Years
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Subjects without cardiovascular disease, cardiovascular related symptoms and risk factors judged by combining clinical manifestations, non-invasive imaging and laboratory examination
You will not qualify if you...
Subjects clinically screened or previously diagnosed with cardiovascular disease and risk factors
Subjects with serious non-cardiovascular diseases
Subjects with poor quality of magnetic resonance imaging
Subjects refused to participate in the study
Subjects with contraindications to MRI
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Diagnostic Evaluation
Duration - Single time point
Participants undergo cardiovascular magnetic resonance imaging to assess cardiac morphology, function, and tissue characteristics.
1 visit (in-person)
Long-term Monitoring
Duration - Up to 5 years
Participants' cardiac normal values are observed over time to establish reference standards.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Study Comparing Pharmacokinetics and Food Effects of Casdatifan Tablets in Healthy Adults Aged 18 to 55
Phase I Study to Evaluate Safety and Drug Behavior of SPH9788 Tablets in Healthy Adults Aged 18 to 45
Phase I Randomized, Double-Blind, Placebo-Controlled Study of Single-Dose SV003 to Assess Safety and Drug Effects in Healthy Adults Aged 18 to 45
Study of Safety, Tolerability, and Body Effects of Single and Multiple Doses of ARO-033 Compared to Placebo in Healthy Adults Aged 18 to 65
Phase 1 Evaluation of Safety and Pharmacokinetics for Single and Multiple Oral Doses of Debio 1453P in Healthy Adults Aged 18 to 55
Study to See How Food Affects the Absorption of Nalbuphine Extended-Release Tablets in Healthy Adults Aged 18 to 60
Phase 1 Study Comparing Navlimetostat Wet-Granulation and Dry-Granulation Tablet Forms in Healthy Adult Women Not of Childbearing Potential
Phase 1 Study of AMG 691 Injection in Healthy Chinese and Japanese Adults Evaluating Drug Behavior and Safety
Phase 1a1b Study Evaluating Safety and Effects of Inhaled Rev-56 in Healthy Adults and Adults with Non-cystic Fibrosis Bronchiectasis with Chronic Pseudomonas Aeruginosa
Phase 1 Study to Assess Safety, Tolerability, and Pharmacokinetics of a Single Subcutaneous Dose of KLA480 Injection in Healthy Adults Aged 18 to 45
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The global cardiovascular magnetic resonance registry (GCMR) of the society for cardiovascular magnetic resonance (SCMR): its goals, rationale, data infrastructure, and current developments.
Global Cardiovascular Magnetic Resonance Registry (GCMR) Investigators, Raymond Y Kwong, Steffen E Petersen...
Quality assessment of cardiovascular magnetic resonance in the setting of the European CMR registry: description and validation of standardized criteria.